Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Statistics

Total Valuation

ABUS has a market cap or net worth of $643.53 million. The enterprise value is $536.42 million.

Market Cap	643.53M
Enterprise Value	536.42M

Important Dates

The last earnings date was Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

ABUS has 191.53 million shares outstanding. The number of shares has increased by 11.76% in one year.

Current Share Class	191.53M
Shares Outstanding	191.53M
Shares Change (YoY)	+11.76%
Shares Change (QoQ)	+0.53%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	51.79%
Float	136.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	99.38
Forward PS	147.97
PB Ratio	8.13
P/TBV Ratio	8.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	83.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.01, with a Debt / Equity ratio of 0.07.

Current Ratio	6.01
Quick Ratio	5.87
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-558.17

Financial Efficiency

Return on equity (ROE) is -79.02% and return on invested capital (ROIC) is -40.69%.

Return on Equity (ROE)	-79.02%
Return on Assets (ROA)	-31.58%
Return on Invested Capital (ROIC)	-40.69%
Return on Capital Employed (ROCE)	-69.21%
Revenue Per Employee	$145,523
Profits Per Employee	-$1.74M
Employee Count	44
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.30% in the last 52 weeks. The beta is 1.50, so ABUS's price volatility has been higher than the market average.

Beta (5Y)	1.50
52-Week Price Change	+0.30%
50-Day Moving Average	3.29
200-Day Moving Average	3.55
Relative Strength Index (RSI)	54.04
Average Volume (20 Days)	817,075

Short Selling Information

The latest short interest is 11.50 million, so 6.01% of the outstanding shares have been sold short.

Short Interest	11.50M
Short Previous Month	11.19M
Short % of Shares Out	6.01%
Short % of Float	8.44%
Short Ratio (days to cover)	13.43

Income Statement

In the last 12 months, ABUS had revenue of $6.40 million and -$76.57 million in losses. Loss per share was -$0.41.

Revenue	6.40M
Gross Profit	-41.19M
Operating Income	-67.54M
Pretax Income	-77.09M
Net Income	-76.57M
EBITDA	-66.18M
EBIT	-67.54M
Loss Per Share	-$0.41

Balance Sheet

The company has $112.71 million in cash and $5.60 million in debt, giving a net cash position of $107.11 million or $0.56 per share.

Cash & Cash Equivalents	112.71M
Total Debt	5.60M
Net Cash	107.11M
Net Cash Per Share	$0.56
Equity (Book Value)	79.16M
Book Value Per Share	0.41
Working Capital	97.38M

Cash Flow

In the last 12 months, operating cash flow was -$58.95 million and capital expenditures -$87,000, giving a free cash flow of -$59.03 million.

Operating Cash Flow	-58.95M
Capital Expenditures	-87,000
Free Cash Flow	-59.03M
FCF Per Share	-$0.31

Margins

Gross Margin	n/a
Operating Margin	-1,054.79%
Pretax Margin	-1,195.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABUS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.76%
Shareholder Yield	-11.76%
Earnings Yield	-11.90%
FCF Yield	-9.17%

Analyst Forecast

The average price target for ABUS is $5.50, which is 63.69% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.50
Price Target Difference	63.69%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	95.66%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ABUS has an Altman Z-Score of -6.91 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.91
Piotroski F-Score	2